Clinical Trials Logo

Filter by:
NCT ID: NCT04787588 Recruiting - Asthma Clinical Trials

COVID-19 Infection and Epithelial Cell Markers

Start date: February 14, 2021
Phase:
Study type: Observational

To assess if TSLP expression by airway epithelial cells following COVID-19 infection regulates viral load and disease severity.

NCT ID: NCT04787536 Recruiting - Postoperative Pain Clinical Trials

Perioperative Cognitive Trajectories in Deferred Surgery (CoTELE-SURGE)

CoTELE-SURGE
Start date: June 10, 2020
Phase:
Study type: Observational

Cognition is the way people use their brains to think, understand, remember and make decisions. Cognitive changes are often seen even up to 1 year after surgery. Whether these changes are more than what is expected for someone's age and morbidities is still uncertain. Due to the COVID-19 emergency, many elective surgeries have been delayed, which is stressful for patients, but also represents an opportunity of understanding better how surgery can impact cognitive abilities. The purpose of this study is to explore if and how cognitive performance changes over time for patients aged 65 years or older, whose surgery has been postponed. due to the COVID-19 emergency, following and assessing the cognitive performance of these patients over time before and after surgery. In particular, in this study, the participant's cognitive performance will be assessed periodically with a computer-based instrument for cognitive testing, self-administered at home, in which tests are based on playing cards.

NCT ID: NCT04787315 Recruiting - Stroke Clinical Trials

Reaching Clinical Recommendations for Intensity of Post-stroke Rehabilitation

Start date: October 5, 2019
Phase: N/A
Study type: Interventional

The project aims to implement workstations for mobility training during intensive inpatient rehabilitation to increase the level of motor activity of individuals with hemiparesis due to stroke

NCT ID: NCT04787289 Recruiting - Ovarian Cancer Clinical Trials

A Comparison of 2 Standard Doses of Bevacizumab in Combination With Chemotherapy in Epithelial Ovarian Cancer

Start date: September 10, 2021
Phase: Phase 2
Study type: Interventional

A pragmatic, two armed, study comparing 2 standard doses of an anti-cancer drug called bevacizumab, given in combination with Chemotherapy. The study will be offered to ovarian cancer patients whose disease is platinum chemotherapy resistant . Higher doses of anti-cancer based drugs are not always better than lower doses and can cause more side effects without improvement of cancer. These patients will be randomly assigned either 7.5 mg/kg or 15mg/kg of bevacizumab combined with chemotherapy . Comparing these two doses will determine if the lower dose-level is non-inferior, and could lead to practice changes.

NCT ID: NCT04786262 Recruiting - Clinical trials for Diabetes Mellitus, Type 1

A Safety, Tolerability, and Efficacy Study of VX-880 in Participants With Type 1 Diabetes

Start date: March 29, 2021
Phase: Phase 1/Phase 2
Study type: Interventional

This study will evaluate the safety, tolerability and efficacy of VX-880 infusion in participants with Type 1 diabetes mellitus (T1D) and impaired awareness of hypoglycemia (IAH) and severe hypoglycemia.

NCT ID: NCT04784858 Recruiting - Parenting Clinical Trials

Integrating a Parenting Intervention Into Substance Use Treatment: A Feasibility Study

Start date: May 1, 2021
Phase:
Study type: Observational

While motherhood is central to the design of maternal integrated substance use treatment programs, "evidence-based" parenting interventions tailored to the needs of the population are rare. Stakeholder engagement has revealed that the evidence-base is not reflective of the needs of client population. With 34 ECD programs in Ontario, ECD programs are unique position to pilot Attachment and Biobehavioral Catch Up (ABC) and see if it is a good fit for their clients and if it is effective and feasible. ABC is 10-week evidence-based parenting intervention for parents who live in the context of complex risk, including mental health, addictions, child welfare involvement, and poverty. Investigators of this project will complete a open label mixed method feasibility pilot study involving active implementation of ABC that will involve: 1. exploration facilitators and barriers of the year-long implementation and training process and 2. exploration of changes in maternal mental health, substance use and parenting outcomes from beginning to end of treatment. Results of this mixed method pilot study will inform a larger trial with a control group and support a funding application to support its completion.

NCT ID: NCT04784494 Recruiting - Depression Clinical Trials

MST for Parkinson's Disease

MST-PD
Start date: September 20, 2021
Phase: N/A
Study type: Interventional

This trial aims to test the feasibility of Magnetic Seizure Therapy (MST) for Depression in patients diagnosed with Parkinson's Disease.

NCT ID: NCT04783597 Recruiting - Pre-Eclampsia Clinical Trials

Early Prediction of Preeclampsia Using arteriaL Stiffness in High-risk prEgnancies

PULSE
Start date: July 12, 2021
Phase:
Study type: Observational

Despite advances in obstetric care, preeclampsia (PE) remains the leading cause of maternal death and disability in both developed and developing countries, contributing to over 70,000 maternal and 500,000 fetal deaths annually worldwide. PULSE was designed using a preventative medicine approach, focusing on improving early detection of PE as opposed to managing symptoms after onset. The study aims to uncover the earliest possible signs of PE using a combination of novel clinical tools and established diagnostic techniques to better identify, track, and manage high risk pregnant women. Specifically, PULSE will be examining the incorporation of a non-invasive test for the measurement of arterial stiffness, which has been shown to be predictive of hypertensive disorders. This test, in combination with a wide range of blood biomarkers, detailed ultrasound imaging, and a comprehensive battery of physical and mental health questionnaires, represents the largest, most comprehensive preventative PE study to date. The results of this work has the potential to revolutionize the way PE and other hypertensive disorders of pregnancy are managed and treated and can serve to inform the design of future preventative clinical research studies.

NCT ID: NCT04782752 Recruiting - Clinical trials for Transplant-Related Lung Cancer

Non-ablative Oligofractionated Radiation Therapy Before Surgical Transplantation As Radiovaccination

NORTh STAR
Start date: April 28, 2021
Phase: N/A
Study type: Interventional

This is a prospective phase I study to determine the safety and feasibility of non-ablative oligofractionated radiation therapy (NORT) before lung transplantation for patients with underlying pulmonary malignancy. We hypothesize that heterogeneous dose distributions could generate a vaccination effect against the tumor by creating anti-tumoral immune response in the body and these patients may be immunized against their tumor which could reduce the risk of cancer recurrence after transplantation despite the anti-rejection medications required for the transplantation.

NCT ID: NCT04782466 Recruiting - Clinical trials for Pediatric Multiple Sclerosis

ATOMIC (Active Teens Multiple Sclerosis) Physical Activity Research Program

Start date: December 1, 2020
Phase: N/A
Study type: Interventional

The investigators have previously shown that youth with MS are very inactive, and that vigorous physical activity is associated with higher levels of well-being and lower MS disease activity in youth. Yet, no effective physical activity interventions have been developed for youth with MS to date. The investigators have taken input from youth with MS to create a Smartphone-based app (the ATOMIC - Active Teens with Multiple Sclerosis - App) that provides tailored physical activity information and coaching, provides tools to increase social connectedness, and promotes physical activity. This proposed research will therefore address the problem of inactivity in youth with MS by studying an intervention to increase physical activity.